Market Cap
$45.92 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$191.43 B |
![]() |
$103.38 B |
![]() |
$92.52 B |
![]() |
$65.90 B |
![]() |
$56.23 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Edwards Lifesciences Corporation is a medical technology company specialized in artificial heart valves and hemodynamic monitoring. Edwards Lifesciences designs, manufactures, and markets surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and critical care catheters.
Edwards Lifesciences Corporation has the following listings and related stock indices.
Stock: NYSE: EW
Stock: BMV: EW
Stock: Bovespa: E1WL34
Stock: FSX: EWL
Stock: XETR: EWL
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.